“Measurable Residual Disease Monitoring by Multiparameter Flow Cytometry and Relapse Prediction in Adult Acute Myeloid Leukemia” (2024) Annals of Leukemia Research, 5(1), pp. 1–6. doi:10.5281/zenodo.22227540.